News, Updates and Publications

2026 iTind™ Procedure Reimbursement Guide

Effective January 1, 2025 two CPT® codes are available for the insertion and removal of the iTind™ device. Please access the iTind™ Reimbursement Guide for further detail.

Temporary Implanted Prostatic Devices Added to AUA Clinical Practice Guideline

The iTind™ procedure is now included in the American Urological Association (AUA) clinical practice guidelines for management of lower urinary tract symptoms (LUTS) attributed to benign prostatic hyperplasia (BPH), also known as enlarged prostate.
View Press Release

Temporary Implanted Nitinol Device vs. Prostatic Urethral Lift: A Matching-adjusted Indirect Comparison

This Matching-adjusted Indirect Comparison of published clinical trials showed that the iTind procedure had a statistically significant improvement in the safety profile while maintaining equivalent efficacy in change in IPSS, QoL, Qmax, PVR, and SHIM compared to PUL treatment for LUTS secondary to BPH three months following treatment and continuing up to one year after treatment. The poster was presented at the 2023 AUA Annual Meeting and the study was published in the Canadian Journal of Urology.
View Press Release

The iTind procedure is intended for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men age 50 and above.